Owen Adams Catherine Insider Trades

Insider Trading History

Track insider trading activity for Owen Adams Catherine. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Agios Pharmaceuticals
Agios Pharmaceuticals AGIO
Director
Holding Value $433k 10,865 shares
Last Trade
Jun 18, 2026 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$96.2k 2,816 shares
$34.16
$39.87
Agios Pharmaceuticals
Agios Pharmaceuticals AGIO
Director
Holding Value $0 0 shares
Last Trade
Jun 18, 2026 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$96.2k 2,816 shares
$34.16
$39.87
Agios Pharmaceuticals
Agios Pharmaceuticals AGIO
Director
Holding Value $596k 14,950 shares
Last Trade
Jun 18, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$611k 17,877 shares
$34.16
$39.87
Agios Pharmaceuticals
Agios Pharmaceuticals AGIO
Director
Holding Value $0 0 shares
Last Trade
Jun 13, 2026 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$58.2k 1,976 shares
$29.46
$39.87
Agios Pharmaceuticals
Agios Pharmaceuticals AGIO
Director
Holding Value $321k 8,049 shares
Last Trade
Jun 13, 2026 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$58.2k 1,976 shares
$29.46
$39.87
Acadia Pharmaceuticals
Acadia Pharmaceuticals ACAD
Chief Executive Officer
Holding Value $384k 14,803 shares
Last Trade
Mar 25, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$250k 11,641 shares
$21.47
$25.92
Acadia Pharmaceuticals
Acadia Pharmaceuticals ACAD
Chief Executive Officer
Holding Value $1.83M 70,530 shares
Last Trade
Mar 24, 2026 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$493k 23,509 shares
$20.96
$25.92
Acadia Pharmaceuticals
Acadia Pharmaceuticals ACAD
Chief Executive Officer
Holding Value $685k 26,444 shares
Last Trade
Mar 24, 2026 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$493k 23,509 shares
$20.96
$25.92
Acadia Pharmaceuticals
Acadia Pharmaceuticals ACAD
Chief Executive Officer
Holding Value $6.82M 263,005 shares
Last Trade
Mar 06, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$7.52M 339,514 shares
$22.16
$25.92
Agios Pharmaceuticals
Agios Pharmaceuticals AGIO
Director
Holding Value $0 0 shares
Last Trade
Jun 20, 2025 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$72.9k 2,120 shares
$34.41
$39.87
Agios Pharmaceuticals
Agios Pharmaceuticals AGIO
Director
Holding Value $242k 6,073 shares
Last Trade
Jun 20, 2025 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$72.9k 2,120 shares
$34.41
$39.87
Agios Pharmaceuticals
Agios Pharmaceuticals AGIO
Director
Holding Value $629k 15,768 shares
Last Trade
Jun 18, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$560k 15,768 shares
$35.50
$39.87
Agios Pharmaceuticals
Agios Pharmaceuticals AGIO
Director
Holding Value $158k 3,953 shares
Last Trade
Jun 13, 2025 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$67.8k 1,977 shares
$34.30
$39.87
Agios Pharmaceuticals
Agios Pharmaceuticals AGIO
Director
Holding Value $78.8k 1,976 shares
Last Trade
Jun 13, 2025 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$67.8k 1,977 shares
$34.30
$39.87
Acadia Pharmaceuticals
Acadia Pharmaceuticals ACAD
Chief Executive Officer
Holding Value $8.29M 319,976 shares
Last Trade
Mar 24, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$5.51M 319,976 shares
$17.23
$25.92

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up